Clinical Trials Logo

Filter by:
NCT ID: NCT04353817 Completed - Cystic Fibrosis Clinical Trials

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes

Start date: June 19, 2020
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of elexacaftor (ELX) / tezacaftor (TEZ) / ivacaftor (IVA) triple combination (TC) in subjects 6 through 11 years of age with cystic fibrosis (CF) who are heterozygous for F508del and a minimal function (MF) mutation (F/MF genotypes).

NCT ID: NCT04353024 Completed - Healthy Clinical Trials

Effects of Dimethyltryptamine in Healthy Subjects

DMT
Start date: June 18, 2021
Phase: Phase 1
Study type: Interventional

N,N-dimethyltryptamine (DMT) is a naturally-occurring psychedelic substance widely used in recreational and spiritual settings. DMT can be used as a tool to induce an altered state of consciousness of interest in psychological and psychiatric research. DMT is rapidly metabolized by monoamine oxidase (MAO) A. Therefore, it is inactive when administered orally and has a very short duration of action when administered parenterally (<20 min).Therefore, an intravenous administration regime including a bolus and maintenance perfusion has been proposed to induce a stable and prolonged DMT experience allowing to study the psychological and autonomic acute effects of DMT. This administration allows to induce and end an altered state safely and quickly. The goal of the present study is to experimentally test different intravenous DMT administration schedules to investigate the subjective and autonomic effects of DMT in healthy subjects.

NCT ID: NCT04352738 Completed - Type 1 Diabetes Clinical Trials

Role of the Liver in Glucose Homeostasis Using Metabolic Imaging

LEMON
Start date: April 15, 2021
Phase:
Study type: Observational

The primary objective of this study is to assess hepatic glucose uptake using non-invasive metabolic imaging in three different populations that differ in terms of insulin and glucose kinetics. Between-group comparison will address the following two hypotheses: i) Hepatic glucose uptake will be lower in participants with type 1 diabetes compared with matched controls due to lack of portal insulin and delayed pharmacokinetics of subcutaneous bolus insulin. ii) Hepatic glucose uptake will be higher in participants after bariatric surgery compared with matched health controls due to accelerated glucose absorption and earlier and higher peak portal glucose and insulin concentrations.

NCT ID: NCT04351503 Completed - Clinical trials for SARS Coronavirus (SARS-CoV-2) Infection

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

Start date: April 9, 2020
Phase:
Study type: Observational

This study is to gain critical knowledge to understand the factors influencing the outcome of a pandemic virus within the city of Basel.

NCT ID: NCT04350515 Completed - Emotional Stress Clinical Trials

Effects of Social Exclusion in The Context of Chronic Embitterment

EMBEX
Start date: December 20, 2019
Phase: N/A
Study type: Interventional

This experimental, anonymous labor study aims to examine how experiences of social exclusion influence individuals in their fairness-behaviour, psychophysical reactions, and emotion regulation depending on their extent of bitterness. Points given for fairness reasons, just world belief, rejection sensitivity, well-being, cognitive emotion regulation strategies, and heart rate variability (HRV) are measured and analyzed using structural equation modeling and multiple regression.

NCT ID: NCT04342780 Completed - Clinical trials for Chemotherapy-induced Nausea and Vomiting

Prevalence of Delayed Chemotherapy Associated Nausea

CINrate
Start date: June 29, 2020
Phase:
Study type: Observational

This study evaluates the prevalence of delayed chemotherapy induced nausea in adult oncology patients in real clinical practice of day clinics.

NCT ID: NCT04339023 Completed - Postoperative Pain Clinical Trials

Open-Label Placebo Treatment for Acute Postoperative Pain

OLP-POP
Start date: May 12, 2020
Phase: N/A
Study type: Interventional

This study is to evaluate whether the amount of morphine intake in acute postoperative pain following minimally invasive Transforaminal Lumbar Interbody Fusion (TLIF) can be decreased with an Open-Label Placebo (OLP) intervention (comprising the administration of sodium chloride (NaCl) injections and an evidence-based treatment rationale) in comparison to a "Treatment As Usual" (TAU) control group.

NCT ID: NCT04338542 Completed - Clinical trials for Mestastatic ColoRectal Cancer

A Retrospective Study Project of Clinico-molecular Characterization in Patients With Metastatic Colorectal Cancer

Start date: April 8, 2020
Phase:
Study type: Observational

This is a retrospective, translational, proof-of-concept study on tumor biopsies done on patients affected by mCRC and exhibiting RAS mutation. For each patient it will be selected the tissue biopsies of primary tumour and of paired resected metastasis.

NCT ID: NCT04338477 Completed - Clinical trials for Urine Specimen Collection

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

Start date: February 12, 2018
Phase: Phase 3
Study type: Interventional

Fluid intake and urinary output are measured with /without intake of Nephrosolid tablets in acute ( 1 day application ) and chronic ( 28 days application) therapy.

NCT ID: NCT04334161 Completed - Clinical trials for Roux-en-y Gastric Bypass

Evaluation of the Neuro-endocrine Response to Post-prandial Hyperinsulinaemic Hypoglycaemia.

DEEP1B
Start date: October 2, 2020
Phase:
Study type: Observational

The primary objective of this study is to assess the neuro-endocrine response to hypoglycaemia in PHH vs. non-PHH post-gastric bypass individuals.